MAP4 is a selective group III metabotropic glutamate receptor antagonist in some electrophysiological systems. It also acts as a group II/group III agonist in certain neurochemical systems. References: Ramkumar A, Jong BY, Ori-McKenney KM. ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. Dev Dyn. 2018 Jan;247(1):138-155. doi: 10.1002/dvdy.24599. Epub 2017 Oct 27. Review. PubMed PMID: 28980356; PubMed Central PMCID: PMC5739964.

纯度：≥98%

CAS：157381-42-5